Libido Supplements: What's Actually in Them
SaveNo over-the-counter supplement is proven to raise female libido, and major gynecology guidance endorses none of them [1]. 'Female libido' blends of maca, fenugreek, and ginseng are sold as dietary supplements, so their dose and purity are not verified. Distressing low desire affects about 1 in 10 women and deserves a real evaluation.
Last updated: July 2026
Continue in Claude
Open a chat with this article’s link already in the message, and keep asking questions there. Claude reads the article and its sources; nothing about you is included.
The button opens the Claude desktop app and fills in the message for you to review before sending. No desktop app, or reading on a phone? Copy the prompt and paste it into any AI.
What do libido supplements actually contain?
Most 'female libido' supplements are blends of botanicals and amino acids, commonly maca root, fenugreek, ginseng, tribulus, and L-arginine, sold as capsules, powders, or gummies. In the United States these products are regulated as dietary supplements, not medicines, so a company does not have to prove they work before selling them. That means the dose, purity, and even the listed ingredients are not independently verified the way a prescription drug is. According to the American College of Obstetricians and Gynecologists, low sexual desire is common and multifactorial, and no over-the-counter supplement has strong evidence behind it 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG Practice Bulletin on female sexual dysfunction: low desire is common, multifactorial, and evaluated individually; distressing low desire affects about 1 in 10 women, roughly 4 in 10 report a sexual concern, and flibanserin and bremelanotide are the FDA-approved prescription options while no OTC supplement has established efficacy.. Marketing language like 'clinically studied blend' rarely reflects a rigorous trial in women.
Does the research support maca, fenugreek, or ginseng?
Evidence for individual botanicals is thin, small, and inconsistent. A handful of short studies suggest maca or fenugreek might modestly affect desire, but the trials are tiny, often industry-funded, and rarely replicated, so guidelines do not endorse them 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG Practice Bulletin on female sexual dysfunction: low desire is common, multifactorial, and evaluated individually; distressing low desire affects about 1 in 10 women, roughly 4 in 10 report a sexual concern, and flibanserin and bremelanotide are the FDA-approved prescription options while no OTC supplement has established efficacy.. Roughly 4 in 10 women report a sexual concern at some point, according to ACOG, yet supplements were never designed or tested to treat it 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG Practice Bulletin on female sexual dysfunction: low desire is common, multifactorial, and evaluated individually; distressing low desire affects about 1 in 10 women, roughly 4 in 10 report a sexual concern, and flibanserin and bremelanotide are the FDA-approved prescription options while no OTC supplement has established efficacy.. By contrast, the interventions with genuine trial evidence are prescription and clinician-monitored. For postmenopausal women, an international consensus statement found that carefully dosed testosterone can add about one satisfying sexual event every 28 days over placebo, a real but modest effect that no supplement has matched 2Ref 2Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019).Global Consensus Position Statement on the Use of Testosterone Therapy for Women.International consensus that carefully monitored testosterone can modestly improve satisfying sexual events in postmenopausal women with low desire (about one additional satisfying sexual event per 28 days versus placebo); it is off-label, prescription-only, and clinician-supervised, not an over-the-counter product..
Are libido supplements safe to take?
'Natural' does not automatically mean safe or inert. Because the supplement industry is loosely regulated, products have been found to contain undisclosed pharmaceutical ingredients, heavy metals, or doses far higher than the label states. Botanicals such as ginseng and tribulus can interact with blood thinners, blood-pressure medicines, and hormone-sensitive conditions, and high-dose L-arginine may lower blood pressure. Because desire is shaped by sleep, stress, relationships, mood, pain, and medication, a pill aimed at one pathway rarely reaches the real driver. Some antidepressants, for example, blunt desire, which is better explored as antidepressant side effects than masked with a supplement.
What actually helps low desire?
Desire responds best to a broad look at the whole picture, not a single capsule. Clinicians typically weigh sleep, stress, relationship dynamics, mood, medications, thyroid and iron levels, pain with sex, and vaginal comfort before reaching for any treatment 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG Practice Bulletin on female sexual dysfunction: low desire is common, multifactorial, and evaluated individually; distressing low desire affects about 1 in 10 women, roughly 4 in 10 report a sexual concern, and flibanserin and bremelanotide are the FDA-approved prescription options while no OTC supplement has established efficacy.. When vaginal dryness or discomfort is part of it, lubricants, moisturizers, or local estrogen often help more than any oral product. Desire is not fixed; it commonly shifts across life stages, dipping in the months after childbirth and again across the perimenopausal transition as estrogen declines, when hormone therapy is sometimes considered 3Ref 3Nastri CO, Lara LA, Ferriani RA, et al. (2013).Hormone therapy for sexual function in perimenopausal and postmenopausal women.Cochrane review finding hormone therapy modestly improves sexual function and lubrication in peri- and postmenopausal women over roughly 12 weeks; basis for the lifecycle framing that desire, arousal, and natural lubrication shift as estrogen falls.. For relationship strain, low sex drive has causes worth naming directly.
When low libido is worth a clinician's time
Persistent low desire that bothers you or strains a relationship is worth a conversation with a clinician rather than a trial-and-error supplement habit. A primary care clinician or gynecologist can check for treatable contributors, such as thyroid problems, anemia, depression, medication effects, or genitourinary symptoms, and review the two FDA-approved prescription options and off-label testosterone where appropriate 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG Practice Bulletin on female sexual dysfunction: low desire is common, multifactorial, and evaluated individually; distressing low desire affects about 1 in 10 women, roughly 4 in 10 report a sexual concern, and flibanserin and bremelanotide are the FDA-approved prescription options while no OTC supplement has established efficacy.2Ref 2Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019).Global Consensus Position Statement on the Use of Testosterone Therapy for Women.International consensus that carefully monitored testosterone can modestly improve satisfying sexual events in postmenopausal women with low desire (about one additional satisfying sexual event per 28 days versus placebo); it is off-label, prescription-only, and clinician-supervised, not an over-the-counter product.. That kind of evaluation is something no gummy or blend can replace. Gale can help you prepare for that conversation and organize what you want to ask.
Common questions
Related
Sexual health
Testosterone for Low Desire: What Evidence SupportsSexual health
Vyleesi (Bremelanotide): An On-Demand OptionSexual health
Addyi (Flibanserin): How Well Does It Work?
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
When low desire deserves a closer look
- —Low desire or arousal that causes real distress or strains a relationship is a reason to seek clinician evaluation
- —New or worsening low desire after starting a medication is a reason to review it with the prescriber
- —Pain during sex that does not ease with lubrication is a reason to see a gynecologist
- —Unusual fatigue, hair thinning, or weight change alongside low desire is a reason to seek clinician review for thyroid or iron problems
This article is general health education, not medical advice. Whether any supplement or treatment is right for you is best decided with a primary care clinician or gynecologist who knows your history and medications.
References
- 1.American College of Obstetricians and Gynecologists (2019). Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000003324 ✓ACOG Practice Bulletin on female sexual dysfunction: low desire is common, multifactorial, and evaluated individually; distressing low desire affects about 1 in 10 women, roughly 4 in 10 report a sexual concern, and flibanserin and bremelanotide are the FDA-approved prescription options while no OTC supplement has established efficacy.
- 2.Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019). Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Journal of Clinical Endocrinology & Metabolism. doi:10.1210/jc.2019-01603 ✓International consensus that carefully monitored testosterone can modestly improve satisfying sexual events in postmenopausal women with low desire (about one additional satisfying sexual event per 28 days versus placebo); it is off-label, prescription-only, and clinician-supervised, not an over-the-counter product.
- 3.Nastri CO, Lara LA, Ferriani RA, et al. (2013). Hormone therapy for sexual function in perimenopausal and postmenopausal women. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD009672.pub2 ✓Cochrane review finding hormone therapy modestly improves sexual function and lubrication in peri- and postmenopausal women over roughly 12 weeks; basis for the lifecycle framing that desire, arousal, and natural lubrication shift as estrogen falls.
3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy